Page last updated: 2024-11-12

ventiloquinone l

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ventiloquinone L: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11415004
CHEMBL ID594257
MeSH IDM0486300

Synonyms (6)

Synonym
rnggdqgpilktqu-jgvffnpusa-
inchi=1/c16h16o5/c1-7-4-10-13(8(2)21-7)16(19)14-11(15(10)18)5-9(20-3)6-12(14)17/h5-8,17h,4h2,1-3h3/t7-,8+/m0/s1
CHEMBL594257
(+)-ventiloquinone
ventiloquinone l
(1r,3s)-9-hydroxy-7-methoxy-1,3-dimethyl-3,4-dihydro-1h-benzo[g]isochromene-5,10-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID453796Inhibition of Xanthomonas vasicola XhoI assessed as pBSKS cleavage at 100 uM by endonuclease assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
AID453793Inhibition of human topoisomerase 2alpha-mediated kinetoplast DNA decatenation at 100 uM2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
AID453795Induction of DNA intercalation in pRYG DNA at 100 uM by agarose gel electrophoresis2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
AID453794Inhibition of human topoisomerase 2alpha-mediated relaxation of double-stranded pRYG DNA at 100 uM by agarose gel electrophoresis2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
AID453797Growth inhibition of Saccharomyces cerevisiae BY4741 after 24 hrs2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Pyranonaphthoquinone derivatives of eleutherin, ventiloquinone L, thysanone and nanaomycin A possessing a diverse topoisomerase II inhibition and cytotoxicity spectrum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]